Pharmafile Logo

TVF Communications

- PMLiVE

Smarter strategies: precise customer-centric digital engagement with the NHS

Having traditionally found itself near the bottom of digital adoption league tables, the scale and maturity of customer engagement practices within the pharmaceutical industry, accelerated by the COVID-19 pandemic, are...

- PMLiVE

Novartis and Voyager Therapeutics agree on gene therapy deal worth 1.7bn

The licence option agreement is for next-generation gene therapy vectors for neurological diseases

- PMLiVE

Novo Nordisk’s collaboration with MIT and BWH expanded

The new agreement means that the collaboration has been extended until 2026

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...

Lucid Group Communications Limited

International Women’s Day 2022 #BreakTheBias

Today is International Women’s Day. This day is about gender equality, which, to be achieved, must involve the calling out of gender bias, discrimination and stereotyping.Individually, we're all responsible for...

Lucid Group Communications Limited

- PMLiVE

Cancer Research UK and Teon Therapeutics announce treatment of first patient in phase 1/2 trial for difficult-to-treat cancers

The trial is currently open to recruitment at The Royal Marsden and additional sites are anticipated to open shortly

- PMLiVE

Motor Neurone Disease Association and tech innovators collaborate to produce I Will Always Be Me

The book, the first of its kind, is for people living with MND and banks their voices as they read aloud

- PMLiVE

International Women’s Day 2022

This year the theme of International Women’s Day is ‘break the bias’, focussing on how our actions in our communities, workplaces, schools and universities can unite our individual actions with...

Mednet

How I’m helping to #BreakTheBias: International Women’s Day

What do you think of when you imagine a scientist? Who do you see in a lab coat? Gender stereotypes and assumptions are rife and, as a child, the thought...

Lucid Group Communications Limited

How do doctors want to engage with pharma on new products?

More than 80% of European doctors agree they are interested in staying up-to-date with new developments about pharmaceutical products. But what influences their choice of treatment and how do they...

M3 (EU)

Virtual collaboration tools to reduce “digital overload”

Considering its impact on our health and productivity, digital overload is clearly something that we need to take seriously.

Impetus Digital

- PMLiVE

FDA approves BMS’ Opdivo with chemotherapy for certain lung cancer patients

This is the first and only immunotherapy-based treatment approved for use before surgery for patients with non-small cell lung cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links